patents
The brief bilateral summit between U.S. President Joe Biden and outgoing German Chancellor Angela Merkel ended Thursday without any commitment from the European leader to drop her opposition to a temporary patent waiver for coronavirus vaccines, a result ...[Read more]
0
Like
Save
){kind=link}
At least nine people involved with companies that develop and manufacture COVID vaccines have become billionaires since the beginning of the pandemic, thanks to the monopoly power of pharmaceutical firms, according to new analysis by global health groups
...[Read more]
0
Like
Save
){kind=link}
Biden and many of his appointees have links to drug companies trying to delay and weaken the COVID vaccine waiver he’s now promising to negotiate. ...[Read more]
0
Like
Save
){kind=link}
In the face of mounting international pressure, the Biden administration on Wednesday announced support for waiving intellectual property protections for Covid-19 vaccines—which campaigners welcomed as "a transformative, hopeful event" that has the pote ...[Read more]
0
Like
Save
){kind=link}
Many industries across the U.S. have expressed alarm over the proposed waiver, which was put forth by a coalition of over 100 countries, led by India and South Africa, and would waive intellectual property rules in order to boost production of vaccines, m ...[Read more]
0
Like
Save
){kind=link}